Stoke Therapeutics STOK
$26.81 −$0.12 (-0.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 +2.20%
Open$26.39
Prev close$26.93
Day range$25.94 – $27.78
Volume615.8K
Market cap$1.75B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$48.33+80.3% vs. price
- Buy 100%
Low $39.00Now $26.81Avg $48.33High $60.00
Recent rating changes
The last 20 actions on file set price targets from $35.00 to $60.00, averaging $46.37.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 2 Nov 2026 | CCORF | BUY | $58.00 |
| 2 Nov 2026 | H.C. Wainwright | BUY | $50.00 |
| 1 Nov 2026 | BTIG | BUY | $39.00 |
| 30 Oct 2026 | Goldman Sachs | BUY | $43.00 |
| 13 Oct 2026 | TD Cowen | BUY | $60.00 |
| 12 Oct 2026 | BTIG | BUY | $39.00 |
| 5 Oct 2026 | Goldman Sachs | BUY | $44.00 |
| 21 Aug 2026 | J.P. Morgan | BUY | $40.00 |
| 12 Aug 2026 | CCORF | BUY | $58.00 |
| 4 Aug 2026 | TD Cowen | BUY | $60.00 |
| 4 Aug 2026 | CCORF | BUY | $58.00 |
| 4 Aug 2026 | Needham | BUY | $40.00 |
| 4 Aug 2026 | H.C. Wainwright | BUY | $50.00 |
| 3 Aug 2026 | Chardan Capital | BUY | $35.00 |
| 3 Aug 2026 | Wolfe Research | BUY | $40.00 |
| 3 Aug 2026 | BTIG | BUY | $39.00 |
| 3 Aug 2026 | Goldman Sachs | BUY | $44.00 |
| 13 Jul 2026 | Goldman Sachs | BUY | $44.00 |
| 9 Jul 2026 | Needham | BUY | $40.00 |
| 2 Jun 2026 | Leerink Partners | BUY | – |
No comments yet — be the first to weigh in on STOK.
Sign in to join the discussion.